[1]
A. R. Arshad, B. Saeed, and I. Khan, “Not all Patients with Severe/Critical COVID-19 Pneumonia Benefit from Tocilizumab”, Pak Armed Forces Med J, vol. 75, no. 4, pp. 626–630, Aug. 2025, doi: 10.51253/pafmj.v75i4.8053.